结核与肺部疾病杂志 ›› 2026, Vol. 7 ›› Issue (2): 156-161.doi: 10.19983/j.issn.2096-8493.20260008

• 专题笔谈 • 上一篇    

结核后肺疾病的研究进展和临床挑战

马志明()   

  1. 广州市胸科医院呼吸与危重症医学科, 广州 510095
  • 收稿日期:2026-01-20 出版日期:2026-04-20 发布日期:2026-04-13
  • 通信作者: 马志明 E-mail:mazhm7777@163.com

Research progress and clinical challenges in post-tuberculosis lung disease

Ma Zhiming()   

  1. Department of Respiratory and Critical Care Medicine, Guangzhou Chest Hospital, Guangzhou 510095, China
  • Received:2026-01-20 Online:2026-04-20 Published:2026-04-13
  • Contact: Ma Zhiming E-mail:mazhm7777@163.com

摘要:

结核病仍是全球致死率最高的单一感染性疾病,约30%~50%的结核病患者治疗后会发展为结核后肺疾病(post-tuberculosis lung disease, PTLD),耐多药结核病患者中PTLD发生率更高,可表现为慢性呼吸道异常,进而引发慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)等并发症,给公共卫生体系带来沉重负担。本文以PTLD亚型异质性与精准管理为主线,阐述其定义与分类,围绕气道病变、肺实质病变、肺血管病变、并发症及合并症、儿童与青少年PTLD等主要亚型展开分析,其病理机制涉及宿主免疫反应、病原体残留及环境因素的交互作用,诊断方法涵盖影像学、肺功能评估及生物标志物检测,治疗与康复在肺康复、药物治疗及预防措施方面取得一定突破。目前,PTLD仍存在诊断标准与评估体系不统一、亚型诊治策略有待完善、亚型相关机制研究薄弱、特殊人群与合并症研究不足等问题。未来需聚焦AI大模型(专科一体机)技术应用、加大公共卫生投入、明确科学研究导向,围绕亚型异质性完善精准管理体系,以此改善PTLD患者预后。

关键词: 结核, 肺疾病, 病理学, 临床, 诊断, 康复

Abstract:

Tuberculosis remains the single infectious disease with the highest mortality rate globally. Approximately 30% to 50% of tuberculosis patients will develop post-tuberculosis lung disease (PTLD) after treatment, and the incidence of PTLD is higher in patients with multidrug-resistant tuberculosis. PTLD can manifest as chronic respiratory abnormalities, leading to complications such as chronic obstructive pulmonary disease (COPD), imposing a heavy burden on public health systems. Focusing on the heterogeneity and precision management of PTLD subtypes, this article elaborates on the definition and classification of PTLD, and analyzes major subtypes including airway lesions, pulmonary parenchymal lesions, pulmonary vascular lesions, complications and comorbidities, as well as PTLD in children and adolescents. The pathological mechanisms involve interactions between host immune responses, pathogen residues, and environmental factors. Diagnostic methods encompass imaging, pulmonary function assessment, and biomarker detection. Breakthroughs have been made in treatment and rehabilitation strategies including pulmonary rehabilitation, pharmacotherapy, and preventive measures. However, PTLD still faces issues such as inconsistent diagnostic criteria and evaluation systems, imperfect diagnosis and treatment strategies for subtypes, weak research on subtype-related mechanisms, and insufficient research on special populations and comorbidities. In the future, it is necessary to focus on the application of AI large model (specialized all-in-one machine) technology, increase investment in public health, clarify the orientation of scientific research, and improve the precision management system around subtype heterogeneity, so as to improve the prognosis of PTLD patients.

Key words: Tuberculosis, Lung diseases, Pathology, clinical, Diagnosis, Rehabilitation

中图分类号: